Glooko Appoints Serdar Akin as Vice President of Product Development and Michelle de Haaff as Vice President of Marketing and Customer Success

Share Article

Diabetes management platform leverages recent investment to grow leadership bench with experienced executives

We are collectively very happy about the new energy, ideas, skills and ‘roll up their sleeves’ attitude that both Serdar and Michelle bring to Glooko.

Glooko Inc., the leading unified platform for diabetes management, today announced the addition of two new executives to its management team. Serdar Akin joins as Vice President of Development and Michelle de Haaff joins as Vice President of Marketing and Customer Success. Both executives come on-board with years of experience in product delivery, marketing and customer experience.

Serdar joins Glooko after 15 years in executive roles at Symantec’s Global Enterprise Security Group and at Intuit Health where he led product management and user experience design. He oversaw a portfolio of products that served over 60,000 healthcare providers and 7 million patients. Mr. Akin was a principal driver behind expanding Intuit’s healthcare focus to include healthcare provider services. This effort resulted in the acquisition of Medfusion, the leading supplier of patient - healthcare provider communication and portal services. At Glooko, Serdar will lead the product management and development team and will focus on continuing to expand the Glooko Unified Platform to include additional device data from insulin pumps, continuous glucose monitoring systems and integration of personalized predictive algorithms.

“Glooko is at a unique time of strong growth and increasing patient and provider engagement,” said Mr. Akin. “I am excited to lead the development team towards continuing to deliver a secure, scalable and intuitive software platform that can improve the lives of people with diabetes and provide management and remote monitoring tools for their care team.”

Michelle joins Glooko after 18 years spent in the customer experience and analytics software industry. She recently came to Glooko from Medallia, an enterprise customer experience SaaS company where she led marketing globally through Medallia’s explosive market growth. Prior to Medallia she led the product, marketing and customer engagement teams at Attensity Software, a SaaS text analytics company. She also led product management at Blue Martini Software, an eCommerce and web analytics company, from its early years through its IPO. Prior, she was a CRM practice leader with Ernst and Young Management Consulting. Her expertise is in the cross section of analytics and customer engagement. Michelle is a passionate and proven leader in the practice of creating customer success. At Glooko, she is building a Glooko customer success team that is focused on ensuring that Glooko’s customers - both patients and healthcare providers - have the optimal customer experience using Glooko.

“I believe Glooko will have impact at a global scale. Millions of people with diabetes and their healthcare providers will have the data and insights they need to make better daily decisions about personal lifestyle choices,” Michelle explained. “Additionally, Glooko is hitting an inflection point – where healthcare doesn’t just happen when a person visits the doctor or is hospitalized, but instead happens 24x7x365 and leverages on-demand data to proactively improve overall health outcomes,” she noted.

“We are collectively very happy about the new energy, ideas, skills and ‘roll up their sleeves’ attitude that both Serdar and Michelle bring to Glooko,” said Rick Altinger, CEO of Glooko. “Serdar’s background in product delivery combined with Michelle’s ability to empathize with and create great customer experiences will take Glooko to the next level in our ability to make diabetes management easier for both patients and their care team,” continued Rick.

This announcement comes on the heels of Glooko’s recent Series B investment that brought $16.5M of additional funds into the business. The investment will be used to fuel expansion of Glooko’s FDA-cleared, HIPAA-compliant platform to include device data from insulin pumps, continuous glucose monitoring systems and integration of personalized predictive algorithms.

About Glooko
Glooko is the world’s leading Unified Platform for Diabetes Management and is trusted by the world’s leaders in diabetes care. Glooko provides an FDA-cleared, HIPAA-compliant Web and Mobile application designed to improve health outcomes for people with diabetes, which in turn reduces costs for payers and the healthcare system. Glooko seamlessly syncs with over 30 blood glucose meters, the world’s major fitness and activity trackers and supplies timely, verified patient data such as blood glucose, carbs, insulin, blood pressure, diet and weight data. Glooko’s mobile app enables patients to easily track and proactively manage all aspects of their diabetes care. Glooko’s population management web app and API’s offers diabetes-centric analytics and supplies insightful reports, graphs and risk flags to health systems and payers. Learn more at http://www.glooko.com and follow us at Twitter.com/GlookoInc, and Facebook.com/Glooko.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Vikram Singh
Glooko, Inc.
+1 (925) 487-1461
Email >
Visit website